Phase I study of ipatasertib as a single agent and in combination with abiraterone plus prednisolone in Japanese patients with advanced solid tumors

por Doi, Toshihiko, Fujiwara, Yutaka, Matsubara, Nobuaki, Tomomatsu, Junichi, Iwasa, Satoru, Tanaka, Akari, Endo-Tsukude, Chihiro, Nakagawa, Shintaro, Takahashi, Shunji
Publicado 2019